FDA Long-Term Globalization Strategy Under Development

"Third-party inspection programs need to be a bigger part of the discussion so that we don't have to do the work all ourselves," said John Taylor, FDA acting principal deputy commissioner. "We simply cannot do it alone."

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet